These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24709260)

  • 1. Luliconazole demonstrates potent in vitro activity against dermatophytes recovered from patients with onychomycosis.
    Wiederhold NP; Fothergill AW; McCarthy DI; Tavakkol A
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3553-5. PubMed ID: 24709260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.
    Carrillo-Muñoz AJ; Giusiano G; Cárdenes D; Hernández-Molina JM; Eraso E; Quindós G; Guardia C; del Valle O; Tur-Tur C; Guarro J
    Int J Antimicrob Agents; 2008 Jun; 31(6):540-3. PubMed ID: 18367383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates.
    Baghi N; Shokohi T; Badali H; Makimura K; Rezaei-Matehkolaei A; Abdollahi M; Didehdar M; Haghani I; Abastabar M
    Med Mycol; 2016 Oct; 54(7):757-63. PubMed ID: 27118804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative agents.
    Carrillo-Muñoz AJ; Quindós G; Del Valle O; Santos P; Giusiano G; Guardia C; Eraso E; Ezkurra PA; Tur-Tur C; Hernández-Molina JM
    J Chemother; 2008 Aug; 20(4):521-3. PubMed ID: 18676237
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
    Salehi Z; Fatahi N; Taran M; Izadi A; Badali H; Hashemi SJ; Rezaie S; Daie Ghazvini R; Ghaffari M; Aala F; Barac A; Khodavaisy S
    J Mycol Med; 2020 Jun; 30(2):100935. PubMed ID: 32139093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of topically used luliconazole vs. terbinafine 1% creams.
    Gnat S; Dyląg M; Łagowski D; Zielinski J
    Mycoses; 2021 Aug; 64(8):967-975. PubMed ID: 33884673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antifungal activity of ME1111, a new topical agent for onychomycosis, against clinical isolates of dermatophytes.
    Ghannoum M; Isham N; Long L
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5154-8. PubMed ID: 26055386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
    Jo Siu WJ; Tatsumi Y; Senda H; Pillai R; Nakamura T; Sone D; Fothergill A
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1610-6. PubMed ID: 23318803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses.
    Clayton YM
    Br J Dermatol; 1994 Apr; 130 Suppl 43():7-8. PubMed ID: 8186143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the antifungal efficacy of terbinafine hydrochloride and ciclopirox olamine containing formulations against the dermatophyte Trichophyton rubrum in an infected nail plate model.
    Täuber A; Müller-Goymann CC
    Mol Pharm; 2014 Jul; 11(7):1991-6. PubMed ID: 24490976
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Rezaei-Matehkolaei A; Khodavaisy S; Alshahni MM; Tamura T; Satoh K; Abastabar M; Shokoohi GR; Ahmadi B; Kord M; Taghipour S; Makimura K; Badali H
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison.
    Hazen KC
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S37-41. PubMed ID: 9594935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections.
    Seidl HP; Jäckel A; Müller J; Schaller M; Borelli C; Polak A
    Mycoses; 2015 Oct; 58(10):610-9. PubMed ID: 26334024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of 8 antifungal agents against geophilic dermatophyte isolates.
    Shamsizadeh F; Zarei Mahmoudabadi A; Shariat Nabavi M; Guillot J; Taghipour S; Rezaei-Matehkolaei A
    Mycoses; 2022 Feb; 65(2):255-262. PubMed ID: 34861084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIC and Upper Limit of Wild-Type Distribution for 13 Antifungal Agents against a Trichophyton mentagrophytes-Trichophyton interdigitale Complex of Indian Origin.
    Shaw D; Singh S; Dogra S; Jayaraman J; Bhat R; Panda S; Chakrabarti A; Anjum N; Chowdappa A; Nagamoti M; Varshney U; Vanam HP; Savio J; Antony M; Rudramurthy SM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.
    Jaiswal A; Sharma RP; Garg AP
    Indian J Dermatol Venereol Leprol; 2007; 73(6):393-6. PubMed ID: 18032857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro determination of the combination of ciclopirox and terbinafine in the treatment of dermatophytosis.
    da Costa B; Pippi B; Chaves M; Agostineto G; Fuentefria AM
    J Mycol Med; 2024 Mar; 34(1):101464. PubMed ID: 38367460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.